Screening for cerebrale arteriovenøsemalformationer ved mb. Osler

Simon Kjær Simonsen, Troels Halfeld Nielsen, Rikke Beese Dalby, Annette Dam Fialla, Bibi Lange, Pernille M Tørring, Anabel Diaz, Anette Drøhse Kjeldsen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


Patients with hereditary haemorrhagic telangiectasia (HHT) are known to suffer from cerebral arteriovenous malformations (CAVMs). In this review, we explore existing literature for bleeding risk, interventional therapy and neuroradiological features in HHT-related CAVMs. Studies estimate the annual intracerebral haemorrhage rate of CAVMs in HHT patients to be 0.667-1.014%. The clinician must balance bleeding risk and the non-negligible procedural risks of interventional therapy. We recommend, in agreement with European guidelines, that screening of asymptomatic HHT patients should only be carried out after careful information.
Bidragets oversatte titelScreening for cerebral arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia
TidsskriftUgeskrift for Læger
Udgave nummer19
StatusUdgivet - 17. maj 2021


Dyk ned i forskningsemnerne om 'Screening for cerebrale arteriovenøsemalformationer ved mb. Osler'. Sammen danner de et unikt fingeraftryk.